packageAvacopan

avacopan

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Avacopan is a complement inhibitor used to treat ANCA-associated vasculitis, including microscopic polyangiitis and granulomatosis with polyangiitis (formerly Wegener's granulomatosis). It is an approved medicine authorised in the European Union, though it remains a relatively specialised treatment.

Summary written by glm-5.3-flash from Wikidata Q27285470 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:avacopan
ATC codes:L04AJ05
DrugBank:DB15011
PubChem CID:49841217
Wikidata:Q27285470
formula:C33H35F4N3O2
molar mass:581.654 g/mol (PubChem CID 49841217)
logP:7.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown